Stay updated with breaking news from Daniel Bensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tyra Biosciences Inc (NASDAQ:TYRA), a biotechnology company focused on developing precision medicines targeting oncogenic drivers of cancer, has reported an insider sell according to the latest SEC filings.
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) shares were down 3.2% during mid-day trading on Monday . The stock traded as low as $14.11 and last traded at $14.69. Approximately 4,929 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 55,555 shares. The stock had previously closed […]
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) shares rose 2.5% during trading on Thursday . The stock traded as high as $15.07 and last traded at $15.01. Approximately 3,254 shares traded hands during trading, a decline of 94% from the average daily volume of 55,580 shares. The stock had previously closed at $14.65. Analyst […]
Wedbush reissued their outperform rating on shares of Tyra Biosciences (NASDAQ:TYRA – Free Report) in a research note published on Friday, Benzinga reports. The brokerage currently has a $27.00 price objective on the stock. Wedbush also issued estimates for Tyra Biosciences’ Q2 2024 earnings at ($0.38) EPS. Separately, HC Wainwright upped their price objective on […]
Tyra Biosciences (NASDAQ:TYRA – Free Report) had its target price boosted by HC Wainwright from $17.00 to $20.00 in a report released on Friday morning, MarketBeat reports. HC Wainwright currently has a buy rating on the stock. Separately, Wedbush initiated coverage on shares of Tyra Biosciences in a research report on Thursday, June 29th. They […]